Search

Your search keyword '"Lavorini, Federico"' showing total 156 results

Search Constraints

Start Over You searched for: Author "Lavorini, Federico" Remove constraint Author: "Lavorini, Federico" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
156 results on '"Lavorini, Federico"'

Search Results

4. Presentation and progression of MPO-ANCA interstitial lung disease

5. Doubts and concerns about COVID-19 uncertainties on imaging data, clinical score, and outcomes

6. Identifying critical inhalation technique errors in Dry Powder Inhaler use in patients with COPD based on the association with health status and exacerbations: findings from the multi-country cross-sectional observational PIFotal study

8. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

11. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

13. Role of prognostic scores in predicting in-hospital mortality and failure of non-invasive ventilation in adults with COVID-19

15. The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study

16. Frequent productive cough: Symptom burden and future exacerbation risk among patients with asthma and/or COPD in the NOVELTY study

17. Is Inhaler Technique Adequately Assessed and Reported in Clinical Trials of Asthma and Chronic Obstructive Pulmonary Disease Therapy? A Systematic Review and Suggested Best Practice Checklist

18. Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers

19. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care

20. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study

24. Retrospective Study on the Features and Outcomes of a Tuscany COVID-19 Hospitalized Patients Cohort: Preliminary Results.

25. Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium

26. The effects of airway disease on the deposition of inhaled drugs

27. Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials.

28. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study

34. Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19

37. The ThinICE protocol: the combination of cryobiopsy and ultraThin bronchoscopy for the peripheral lung nodule.

38. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

39. Successful Use of Easyhaler®Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials

40. Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study.

42. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study.

44. Clinical implications of interstitial pneumonia with autoimmune features diagnostic criteria in idiopathic pulmonary fibrosis: A case control study

46. Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes

47. Phenotypes of Post-COVID-19 Interstitial Lung Disease: Clinical, Radiological, and Pathological Correlations

48. Contemporary Challenges in the Management of Asthma and Chronic Obstructive Pulmonary Disease: Expert Perspectives on Optimising Outcomes Through Guidelines Implementation, Inhaler Selection, and Patient Engagement

49. Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs

50. Utility of bronchoalveolar lavage for COVID-19: a perspective from the Dragon consortium.

Catalog

Books, media, physical & digital resources